Leading Financial Service Provider in India | Canara Bank Securities Ltd

Aurobindo Pharma Ltd.

Nov 06, 01:34 BSE 1796.80 (+ 8.50 0.48%)

Volume42309

Prev. Close
1788.30

Open Price
1771.30

Today's Low / High

1771.30 1805.00

Bid. Price (Qty.)1795.90 (18)

Offer Price (Qty.)
1797.40 (2)

52 Wk Low / High

1106.25 1796.95

Nov 06, 01:14 NSE 1797.40(+ 12.40 0.69%)

Volume863604

Prev. Close
1785.00

Open Price
1784.30

Today's Low / High

1776.00 1805.00

Bid Price (Qty.)1797.50 (27)

Offer Price (Qty.)
1797.80 (1)

52 Wk Low / High

1106.00 1796.80

Market Cap. ( ₹ in Cr. )	104393.28	P/BV	2.68	Book Value ( ₹ )	670.19
52 Week High/Low ( ₹ )	1797/1106	FV/ML	1/1	P/E(X)	29.79
Book Closure	11/11/2026	EPS ( ₹ )	60.34	Div Yield (%)	0.22

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	5808.02	5808.02	5859.39	5859.39	5859.39

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	58.08	58.08	58.59	58.59	58.59
Total Share Capital	58.08	58.08	58.59	58.59	58.59

Reserves and Surplus	37832.89	32595.24	29784.21	26781.26	24517.39
Total Reserves and Surplus	37832.89	32595.24	29784.21	26781.26	24517.39
Total Shareholders Funds	37890.97	32653.32	29842.80	26839.85	24575.98
Minority Interest	-8.16	-6.39	8.00	12.00	-1.93

NON-CURRENT LIABILITIES
Long Term Borrowings	802.75	1561.65	2134.90	618.96	249.21
Deferred Tax Liabilities [Net]	306.00	303.27	356.56	389.61	410.96
Other Long Term Liabilities	1071.17	307.85	304.42	363.07	359.73
Long Term Provisions	400.41	282.93	225.70	172.72	171.79
Total Non-Current Liabilities	2580.33	2455.70	3021.58	1544.36	1191.69

CURRENT LIABILITIES
Short Term Borrowings	6873.45	6380.03	4180.32	4242.56	2123.56
Trade Payables	5567.27	4188.85	4454.16	3871.31	2703.05
Other Current Liabilities	5245.25	3837.90	3307.86	3179.38	3158.81
Short Term Provisions	353.04	275.56	256.79	200.53	170.56
Total Current Liabilities	18039.01	14682.34	12199.13	11493.78	8155.98

Total Capital And Liabilities	58502.15	49784.97	45071.51	39889.99	33921.72

ASSETS
NON-CURRENT ASSETS
Tangible Assets	14329.93	12189.43	11545.51	7995.38	7728.44
Intangible Assets	2276.50	1986.74	2352.13	2432.24	2328.23
Capital Work-In-Progress	3008.83	3266.00	2739.39	4496.40	2937.56
Intangible Assets Under Development	2204.73	1633.96	1129.33	893.61	809.64
Fixed Assets	21819.99	19076.13	17766.36	15817.63	13803.87
Goodwill On Consolidation	800.15	618.02	595.15	596.07	475.42
Non-Current Investments	303.88	251.70	94.78	391.74	618.30
Deferred Tax Assets [Net]	1483.59	1292.96	1212.64	677.49	288.59
Long Term Loans And Advances	7.57	6.74	226.87	5.57	6.32
Other Non-Current Assets	1378.22	1376.96	970.08	855.82	606.53
Total Non-Current Assets	25793.40	22622.51	20865.88	18344.32	15799.03


CURRENT ASSETS
Current Investments	747.24	0.01	50.58	151.00	378.85
Inventories	12052.94	10543.72	9808.23	8511.23	7553.85
Trade Receivables	7094.37	5745.93	4816.74	4466.38	4012.26
Cash And Cash Equivalents	9870.29	8235.49	6278.30	6084.20	4190.01
Short Term Loans And Advances	17.87	15.56	12.86	12.43	12.71
OtherCurrentAssets	2926.04	2621.75	3238.92	2320.43	1975.01
Total Current Assets	32708.75	27162.46	24205.63	21545.67	18122.69

Total Assets	58502.15	49784.97	45071.51	39889.99	33921.72

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	3635.70	3271.81	3323.11	1813.21	1145.45

BONUS DETAILS
Bonus Equity Share Capital	46.55	46.55	46.55	46.55	46.55

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	90.76	103.02	136.45	208.23	317.59
Non-Current Investments Unquoted Book Value	104.28	103.14	90.42	93.51	221.36

CURRENT INVESTMENTS
Current Investments Quoted Market Value	747.24	0.01	0.01	81.87	378.85
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.70

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00
No. of Equity Shares (in Lacs)	5808.02

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	58.08
Total Share Capital	58.08
Reserves and Surplus	37832.89
Total Reserves and Surplus	37832.89
Total Shareholders Funds	37890.97
Minority Interest	-8.16
NON-CURRENT LIABILITIES
Long Term Borrowings	802.75
Deferred Tax Liabilities [Net]	306.00
Other Long Term Liabilities	1071.17
Long Term Provisions	400.41
Total Non-Current Liabilities	2580.33
CURRENT LIABILITIES
Short Term Borrowings	6873.45
Trade Payables	5567.27
Other Current Liabilities	5245.25
Short Term Provisions	353.04
Total Current Liabilities	18039.01
Total Capital And Liabilities	58502.15
ASSETS
NON-CURRENT ASSETS
Tangible Assets	14329.93
Intangible Assets	2276.50
Capital Work-In-Progress	3008.83
Intangible Assets Under Development	2204.73
Fixed Assets	21819.99
Goodwill On Consolidation	800.15
Non-Current Investments	303.88
Deferred Tax Assets [Net]	1483.59
Long Term Loans And Advances	7.57
Other Non-Current Assets	1378.22
Total Non-Current Assets	25793.40
CURRENT ASSETS
Current Investments	747.24
Inventories	12052.94
Trade Receivables	7094.37
Cash And Cash Equivalents	9870.29
Short Term Loans And Advances	17.87
OtherCurrentAssets	2926.04
Total Current Assets	32708.75
Total Assets	58502.15
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	3635.70
BONUS DETAILS
Bonus Equity Share Capital	46.55
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	90.76
Non-Current Investments Unquoted Book Value	104.28
CURRENT INVESTMENTS
Current Investments Quoted Market Value	747.24
Current Investments Unquoted Book Value	0.00

Markets

Balance Sheet

BALANCE SHEET

Aurobindo Pharma Ltd.